N4 Pharma PLC (N4P) - Total Liabilities

Latest as of June 2025: GBX78.37K GBX ≈ $9.53 USD

Based on the latest financial reports, N4 Pharma PLC (N4P) has total liabilities worth GBX78.37K GBX (≈ $9.53 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore N4P net asset momentum to track the company's year-over-year net asset growth rate.

N4 Pharma PLC - Total Liabilities Trend (1985–2024)

This chart illustrates how N4 Pharma PLC's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of N4 Pharma PLC to measure how efficiently the company converts operating cash flow to free cash.

N4 Pharma PLC Competitors by Total Liabilities

The table below lists competitors of N4 Pharma PLC ranked by their total liabilities.

Company	Country	Total Liabilities
AIQ Ltd LSE:AIQ	UK	GBX1.25 Million
Vox Valor Capital Ltd. LSE:VOX	UK	GBX5.95 Million
Alba Mineral Resources LSE:ALBA	UK	GBX409.00K
Firering Strategic Minerals Plc LSE:FRG	UK	GBX1.77 Million
Mothercare PLC LSE:MTC	UK	GBX36.40 Million
Ahlers AG F:AAH	Germany	€105.97 Million

Liability Composition Analysis (1985–2024)

This chart breaks down N4 Pharma PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is N4 Pharma PLC worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	23.55	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.04	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.04	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how N4 Pharma PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for N4 Pharma PLC (1985–2024)

The table below shows the annual total liabilities of N4 Pharma PLC from 1985 to 2024.

Year	Total Liabilities	Change
2024-12-31	GBX124.37K ≈ $15.13	+52.18%
2023-12-31	GBX81.73K ≈ $9.94	+4.93%
2022-12-31	GBX77.89K ≈ $9.48	-63.39%
2021-12-31	GBX212.73K ≈ $25.88	+25.81%
2020-12-31	GBX169.08K ≈ $20.57	+117.66%
2019-12-31	GBX77.68K ≈ $9.45	-59.14%
2018-12-31	GBX190.12K ≈ $23.13	+6.08%
2017-12-31	GBX179.22K ≈ $21.81	+132.75%
2016-12-31	GBX77.00K ≈ $9.37	+352.94%
2015-12-31	GBX17.00K ≈ $2.07	-97.89%
2014-12-31	GBX807.00K ≈ $98.19	-10.53%
2013-12-31	GBX902.00K ≈ $109.75	-27.43%
2012-12-31	GBX1.24 Million ≈ $151.24	-15.21%
2011-12-31	GBX1.47 Million ≈ $178.37	+41.51%
2010-12-31	GBX1.04 Million ≈ $126.05	-10.69%
2009-12-31	GBX1.16 Million ≈ $141.14	+109.39%
2008-12-31	GBX554.00K ≈ $67.41	+4.53%
2007-12-31	GBX530.00K ≈ $64.49	+4.13%
2006-12-31	GBX509.00K ≈ $61.93	-86.84%
2005-12-31	GBX3.87 Million ≈ $470.75	-4.89%
2004-12-31	GBX4.07 Million ≈ $494.96	-13.72%
2003-12-31	GBX4.71 Million ≈ $573.68	-2.82%
2002-12-31	GBX4.85 Million ≈ $590.35	-6.84%
2001-12-31	GBX5.21 Million ≈ $633.66	-35.17%
2000-12-31	GBX8.03 Million ≈ $977.38	-8.04%
1999-12-31	GBX8.73 Million ≈ $1.06K	-13.52%
1998-12-31	GBX10.10 Million ≈ $1.23K	-61.40%
1997-12-31	GBX26.17 Million ≈ $3.18K	+11.12%
1996-12-31	GBX23.55 Million ≈ $2.87K	-6.58%
1995-12-31	GBX25.21 Million ≈ $3.07K	+33.58%
1994-12-31	GBX18.88 Million ≈ $2.30K	+55.53%
1993-12-31	GBX12.14 Million ≈ $1.48K	-33.39%
1992-12-31	GBX18.22 Million ≈ $2.22K	-9.15%
1991-12-31	GBX20.05 Million ≈ $2.44K	+223.44%
1990-12-31	GBX6.20 Million ≈ $754.36	-13.95%
1989-12-31	GBX7.21 Million ≈ $876.64	+0.63%
1988-12-31	GBX7.16 Million ≈ $871.16	+17.11%
1987-12-31	GBX6.11 Million ≈ $743.90	+30.17%
1986-12-31	GBX4.70 Million ≈ $571.49	-15.96%
1985-12-31	GBX5.59 Million ≈ $680.02	--

About N4 Pharma PLC

LSE:N4P UK Drug Manufacturers - Specialty & Generic

Market Cap

$48.10K

GBX395.33 Million GBX

Market Cap Rank

#31498 Global

#1204 in UK

Share Price

GBX0.48

Change (1 day)

+0.00%

52-Week Range

GBX0.43 - GBX0.73

All Time High

GBX32.90